Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/20/2014WO2014041140A1 Methods of treating hair related conditions
03/20/2014WO2014041125A1 Specific inhibitors of protein p21 as therapeutic agents
03/20/2014WO2014041106A1 Triazole carboxamide derivatives
03/20/2014WO2014041088A2 Combined treatment with netrin-1 interfering drug and chemotherapeutic drug
03/20/2014WO2014041071A1 Semifluorinated alkane compositions
03/20/2014WO2014041055A1 Compositions comprising mixtures of semifluorinated alkanes
03/20/2014WO2014041007A1 Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson's disease
03/20/2014WO2014040994A1 Compositions comprising peg and ascorbate
03/20/2014WO2014040969A1 2-oxo-2,3-dihydro-indoles for the treatment of cns disorders
03/20/2014WO2014040965A1 Inhibitors of bruton's tyrosine kinase
03/20/2014WO2014040938A1 Non-annulated thiophenylamides as inhibitors of fatty acid binding proteini(fabp) 4 and/or 5
03/20/2014WO2014040936A1 Solid forms of (s)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzo[b]thiophen-7-yl}-propionic acid and of salts thereof
03/20/2014WO2014040921A1 A pharmaceutical composition
03/20/2014WO2014040837A1 Isoxazolidine derivatives
03/20/2014WO2014040742A1 Treatment of heart disease through modulation of hypoxia-induced erna activity
03/20/2014WO2014040577A1 A stable pharmaceutical formulation containing vardenafil hydrochloride
03/20/2014WO2014040555A1 Nitrogen-containing heteroaromatic ring derivative as tyrosine kinase inhibitor
03/20/2014WO2014040549A1 Alkynyl heteroaromatic ring compound and application thereof
03/20/2014WO2014040548A1 Metoprolol sustained-release drug and preparation method therefor
03/20/2014WO2014040528A1 Crystallized polymorph of carboxylamide compound l-malate
03/20/2014WO2014040524A1 Use of 3-n-butyl isoindoline ketone in preparation of drugs for preventing and treating cerebral infarction
03/20/2014WO2014040476A1 Process for synthesising brominated eneyne compound e, e-22-bromo-9,11,19-triyne-17,21-diene docosanoic acid ester
03/20/2014WO2014040373A1 Pi3k and/or mtor inhibitor
03/20/2014WO2014040280A1 Cocrystal of piperacillin sodium and sulbactam sodium and preparation method thereof, as well as pharmaceutical compositions containing same and uses thereof
03/20/2014WO2014040243A1 N-substituted phenyl-n'-substituted heterocyclic urea compound and application thereof as anticancer medicament
03/20/2014WO2014040242A1 3-chloro- and 3-methoxy-n-methyl-2-pyridine carboxamide compound and application thereof as anticancer medicament
03/20/2014WO2014040228A1 Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it
03/20/2014WO2014040164A1 Processes for the preparation of 3-alkyl indoles
03/20/2014WO2014040122A1 Nutritional supplement containing iron
03/20/2014WO2014021591A3 Novel compound, method for preparing same and pharmaceutical composition comprising same
03/20/2014WO2014018932A3 Effluz inhibitor compositions and methods of treatment using the same
03/20/2014WO2014018888A4 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as tak1 inhibitors in disease treatment
03/20/2014WO2014016548A3 Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
03/20/2014WO2014013511A3 Rufinamide solid dispersion
03/20/2014WO2014012050A3 Compounds for treatment of spinal muscular atrophy
03/20/2014WO2014009833A3 Complement pathway modulators and uses thereof
03/20/2014WO2014008118A3 Method for concurrent treatment of pain and depression
03/20/2014WO2014007772A3 Inhalation compositions comprising glucose anhydrous
03/20/2014WO2014007770A3 Inhalation compositions comprising corticosteroid and sorbitol
03/20/2014WO2014006601A3 Nanoparticle compositions of antibacterial compounds and other uses thereof
03/20/2014WO2014006571A3 Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof
03/20/2014WO2014002058A3 Complement pathway modulators and uses thereof
03/20/2014WO2014002051A3 Complement pathway modulators and uses thereof
03/20/2014WO2013192274A3 Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
03/20/2014WO2013190455A3 Process for the preparation of lurasidone hydrochloride
03/20/2014WO2013188417A3 Treatment and prevention of cardiovascular disease and thrombosis
03/20/2014WO2013181586A3 Methods related to bevacizumab
03/20/2014WO2013164841A3 A method of treatment for acne and an anti-acne formulation
03/20/2014WO2013164512A3 Composition for use in the treatment and/or prevention of ocular inflammation, oxidative stress and neovascularization
03/20/2014WO2013152193A3 Methods of treating proliferative disorders with malate or derivatives thereof
03/20/2014WO2013151719A3 Fluorinated oxazolidinone derivatives
03/20/2014WO2013023319A8 In vitro method for modification of the depletion profile of regulatory t cells present in a total population of splenocytes in a sample, culture and exposure of said cells to a medium with atp and polymyxin b
03/20/2014WO2012019154A3 Methods and compositions for malic enzyme 2 (me2) as a target for cancer therapy
03/20/2014WO2012015944A3 Novel tetrahydronaphtalene antagonists to the thromboxane a2 (tp) receptor
03/20/2014WO2012012609A3 Synthesis of resveratrol-based compounds
03/20/2014WO2011163424A3 Substituted 2-(9h-purin-9-yl) acetic acid analogues as inhibitors of stat3
03/20/2014WO2011163231A3 Combination therapy for the treatment of diabetes
03/20/2014WO2011149874A3 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
03/20/2014WO2011130694A3 High molecular weight zwitterion-containing polymers
03/20/2014WO2011066082A3 Markers associated with ribavirin-induced anemia
03/20/2014WO2011057208A3 Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
03/20/2014WO2011020032A3 Pharmaceutical dosage form
03/20/2014WO2010127099A3 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
03/20/2014WO2010110908A3 Transdermal venous access locking solution
03/20/2014US20140081169 System and method of tetherless insufflation in colon capsule endoscopy
03/20/2014US20140080918 Therapeutic solution concentrate
03/20/2014US20140080915 Abuse-proofed dosage forms
03/20/2014US20140080914 Aqueous acrylamide solution, stabilizer for aqueous acrylamide solution, and stabilization method for aqueous acrylamide solution
03/20/2014US20140080913 Sensory-Specific Local Anesthesia and Prolonged Duration Local Anesthesia
03/20/2014US20140080910 Compounds for the treatment of autism in a baby child
03/20/2014US20140080909 Stable pharmaceutical composition and methods of using same
03/20/2014US20140080908 Compositions and methods for improving or preventing depression-like symptoms
03/20/2014US20140080907 Liver regeneration accelerator comprising betaine
03/20/2014US20140080906 Fat emulsion providing taste masking for active health and wellness ingredients
03/20/2014US20140080903 Application of alpha-mangostin in preparation of medicaments for alzheimer's disease
03/20/2014US20140080901 Nanoparticle formulations and uses thereof
03/20/2014US20140080899 miR-33 Inhibitors and Uses Thereof to Decrease Inflammation
03/20/2014US20140080897 Hyaluronic acid-nucleic acid conjugate and composition for nucleic acid delivery containing the same
03/20/2014US20140080896 Identification of small molecules that facilitate therapeutic exon skipping
03/20/2014US20140080895 Combination of anti-clusterin oligonucleotide with hsp90 inhibitor for the treatment of prostate cancer
03/20/2014US20140080892 Antisense modulation of fibroblast growth factor receptor 4 expression
03/20/2014US20140080890 Use of glycopyrrolate for treating tachycardia
03/20/2014US20140080889 Statin and Omega-3 Fatty Acids for Lipid Therapy
03/20/2014US20140080888 Methods for increasing endurance and fat metabolism in humans
03/20/2014US20140080887 Methods for improving linear growth response in children
03/20/2014US20140080886 Methods for Treating HCV
03/20/2014US20140080885 Methods of treating traumatic brain injury
03/20/2014US20140080881 Liquid Formulations of Bendamustine
03/20/2014US20140080880 Bendamustine Formulations
03/20/2014US20140080879 Factor viia inhibitor
03/20/2014US20140080876 Antimicrobial and radioprotective compounds
03/20/2014US20140080875 3,4-diaminopyridine tartrate and phosphate, pharmaceutical compositions and uses thereof
03/20/2014US20140080874 Methods For Treating Inflammation
03/20/2014US20140080873 Treatment of cerebral ischemia
03/20/2014US20140080870 Transdermal Delivery Systems
03/20/2014US20140080869 Methods for Treating HCV
03/20/2014US20140080868 Methods for Treating HCV
03/20/2014US20140080867 Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
03/20/2014US20140080864 Pharmacetuical composition comprising drotaverine
03/20/2014US20140080861 Heterocyclic compounds iwth affinity to muscarinic receptors
1 ... 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 ... 7860